Pro-Pharmaceuticals
Manufacturing · 51-200 Employees
View Company Info for Free
Overview
Phone Number
(617) 559-0033Website
www.pro-pharmaceuticals.comRevenue
$22.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Pro-Pharmaceuticals
Pro-Pharmaceuticals, Inc. specializes in developing innovative cancer therapies, particularly through its carbohydrate linker technology designed to enhance existing anti-cancer agents. The company is actively involved in clinical trials, including Phase I studies of its product DAVANAT for various solid tumors. Its intended clients primarily include cancer patients and healthcare institutions engaged in oncology. Pro-Pharmaceuticals also emphasizes collaboration with experts in carbohydrate chemistry and clinical development to advance its research and product offerings.Explore more
Popular SearchesPro-Pharmaceuticals IncPro PharmaceuticalsPro - Pharmaceuticals IncPro Pharmaceuticals IncSIC Code 28,283NAICS Code 32,325Show more
Pro-Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pro-Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Pro-Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Pro-Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Pro-Pharmaceuticals recently announced quarterly report
Pro-Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Pro-Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Pro-Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Pro-Pharmaceuticals has new funding data
Check if Pro-Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Pro-Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Pro-Pharmaceuticals
Compare insights from companies similar to Pro-Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$13.5M
51-200
Private
-
2019
Kristin PolsenskiChief of Staff to CEO & Vice President, Portfolio, Program & Alliance Management
Company Profile Activity
Activity Insights
Pro-Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pro-Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pro-Pharmaceuticals.
Pro-Pharmaceuticals Tech Stack
A closer look at the technologies used by Pro-Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pro-Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Pro-Pharmaceuticals, Inc. specializes in developing innovative cancer therapies, particularly through its carbohydrate linker technology designed to enhance existing anti-cancer agents. The company is actively involved in clinical trials, including Phase I studies of its product DAVANAT for various solid tumors. Its intended clients primarily inclu... Read More
